# LANREOTIDE ACETATE
> **ANDA218217** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2026-09-18
## Drug
- **FDA Application Number:** ANDA218217
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LANREOTIDE ACETATE
- **Generic name:** Lanreotide Acetate
- **Active ingredients:** LANREOTIDE ACETATE
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **First approval:** 2026-09-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218217)
---
*MORVS · CC0 1.0*